Unified model involving genomics, magnetic resonance imaging and prostate‐specific antigen density outperforms individual co‐variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer

BACKGROUND: Active surveillance (AS) is the reference standard treatment for the management of low risk prostate cancer (PCa). Accurate assessment of tumor aggressiveness guides recruitment to AS programs to avoid conservative treatment of intermediate and higher risk patients. Nevertheless, underes...

Descripción completa

Detalles Bibliográficos
Autores principales: Beksac, Alp Tuna, Ratnani, Parita, Dovey, Zachary, Parekh, Sneha, Falagario, Ugo, Roshandel, Reza, Sobotka, Stanislaw, Kewlani, Deepshikha, Davis, Avery, Weil, Rachel, Bashorun, Hafis, Jambor, Ivan, Lewis, Sara, Haines, Kenneth, Tewari, Ashutosh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955055/
https://www.ncbi.nlm.nih.gov/pubmed/34931468
http://dx.doi.org/10.1002/cnr2.1492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955055/
https://www.ncbi.nlm.nih.gov/pubmed/34931468
http://dx.doi.org/10.1002/cnr2.1492

Ejemplares similares